Agenus Appoints Robert B. Stein, MD, Phd, As Chief Scientific Officer
Published: Jan 13, 2014
LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (NASDAQ: AGEN), a biotechnology company developing novel immune system activating treatments for cancers and infectious diseases, today announced the appointment of Robert B. Stein, M.D., Ph.D., to the newly-created position of Chief Scientific Officer (CSO).
Help employers find you! Check out all the jobs and post your resume.